ஆண்டு அமெரிக்கன் சமூகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்டு அமெரிக்கன் சமூகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்டு அமெரிக்கன் சமூகம் Today - Breaking & Trending Today

Fate Therapeutics Inc (FATE) Q1 2021 Earnings Call Transcript


Operator
Good day, ladies and gentlemen and welcome to the Fate Therapeutics First Quarter 2021 Financial Results Conference Call. This call is being webcast live on the Investors section of Fate Therapeutics website at fatetherapeutics.com. [Operator Instructions]
I will now turn the call over to Scott Wolchko, President and CEO of Fate Therapeutics. Scott, you may begin.
Scott Wolchko
President And Chief Executive Officer
Thank you. Good afternoon and thanks everyone for joining us for the Fate Therapeutics first quarter 2021 financial results call. Shortly after 4:00 p.m. Eastern Time today, we issued a press release with these results, which can be found on the Investors section of our website under Press Releases. In addition, our Form 10-Q for the quarter ended March 31, 2021 was filed shortly thereafter and can be found on the Investors section of our website under Financial Information. Before we begin, I would like to remind everyone that except for ....

United States , Robyn Karnauskas , Jeff Miller , Ted Tenthoff Piper Sandler , Alethia Young Cantor , Sarah Cooley , Alethia Young , Wayne Chu , Michael Yee , Peter Lawson , Edward Dulac , Yigal Nochomovitz , Scott Wolchko , Piper Sandler , Bob Valamehr , Sloan Kettering , Ed Dulac , Robyn Karnauskas Truist , Michael Yee Jefferies , Ted Tenthoff , Peter Lawson Barclays , Yigal Nochomovitz Citi , Development Officer , American Society Of Clinical Oncology Annual Meeting , Fate Therapeutics Inc , American Society Of Gene ,

Locanabio Announces Upcoming Preclinical Data Presentations at American Society of Gene and Cell Therapy Annual Meeting


Locanabio Announces Upcoming Preclinical Data Presentations at American Society of Gene and Cell Therapy Annual Meeting
News provided by
Share this article
Share this article
SAN DIEGO, May 5, 2021 /PRNewswire/  Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-changing therapies for patients with severe neurodegenerative, neuromuscular and retinal diseases, today announced that new data from its preclinical research will be highlighted in oral and poster presentations at the 24th Annual American Society of Gene and Cell Therapy (ASGCT) Meeting, taking place virtually from May 11-14, 2021. The presentations include results from a preclinical
in vivo study showing a novel PUF RNA-binding protein system delivered via an adeno-associated virus serotype 9 (AAV9) vector is safe and effective in eliminating toxic CUG repeats in a mouse model of myotonic dystrophy type 1 (DM1). Data also provide insights on the potential of a unique ....

United States , Haydee Gutierrez , Dimitrios Zisoulis , Nandini Narayan , Scott Davis , Ranjan Batra , Shawn Lee , Greg Nachtrab , Dan Gibbs , Alistair Wilson , Dimitrios Angelis , Daniela Martino Roth , Claire Geddes , Daniela Roth , American Society Of Gene , Locanabio Inc , Berry Company , Annual American Society , Cell Therapy , System Corrects Molecular , Functional Defects , Myotonic Dystrophy Type , Aaron Berlin , Targeting Gene Therapy Approach , Syndrome Type , Rea Lardelli ,